Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.17 USD | -1.40% | -13.98% | +21.81% |
May. 09 | Adverum Biotechnologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 30 | HC Wainwright Starts Adverum Biotechnologies With Buy Rating, $30 Price Target | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.81% | 190M | |
+5.66% | 111B | |
+11.23% | 105B | |
-12.15% | 22.34B | |
-2.68% | 21.93B | |
-5.61% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- ADVM Stock
- News Adverum Biotechnologies, Inc.
- Transcript : Adverum Biotechnologies, Inc., Q2 2019 Earnings Call, Aug 08, 2019